VCBeat Health Contact Us
Home MaaT Pharma Reports Positive Phase 3 ARES Trial Results for Microbiome Therapy MaaT013 in Steroid- and Ruxolitinib-Refractory GI-aGvHD

MaaT Pharma Reports Positive Phase 3 ARES Trial Results for Microbiome Therapy MaaT013 in Steroid- and Ruxolitinib-Refractory GI-aGvHD

Jun 11, 2026 11:13 CST Updated 11:26